The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study
-
Published:2024-02-04
Issue:3
Volume:29
Page:258-265
-
ISSN:1341-9625
-
Container-title:International Journal of Clinical Oncology
-
language:en
-
Short-container-title:Int J Clin Oncol
Author:
Yıldırım Hasan ÇağrıORCID, Kutlu Yasin, Mutlu Emel, Aykan Musa Barış, Korkmaz Mustafa, Yalçın Selim, Şakalar Teoman, Celayir Özde Melisa, Kayıkçıoğlu Erkan, Aslan Ferit, Hafızoğlu Emre, Altıntaş Yunus Emre, Keskinkılıç Merve, Chalabiyev Elvin, Çelebi Abdussamet, Dursun Bengü, Kapar Caner, Özen Miraç, Acar Ömer, Dülgar Özgecan, Kut Engin, Biter Sedat, Kus Fatih, Almuradova Elvina, Erdoğan Atike Pınar, Saray Seray, Güven Deniz Can, Şimşek Eda Tanrıkulu, Üskent Necdet, Kemal Yasemin, Çakar Burcu, Açıkgöz Özgür, Kılıçkap Saadettin, Aksoy Sercan
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 71:209–249 2. Xia C, Dong X, Li H et al (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J 135:584–590 3. Ferzoco RM, Ruddy KJ (2016) The epidemiology of male breast cancer. Curr Oncol Rep 18:1 4. Giordano SH, Cohen DS, Buzdar AU et al (2004) Breast carcinoma in men: a population-based study. Cancer 101:51–57 5. O’leary B, Finn RS, Turner NC (2016) Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol 13:417–30
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|